News & Events
Press Releases
Dec 19, 2024
Modiblast publishes preclinical in vivo data and initial human data on novel cancer cell-reprogramming approach in AML
Modiblast announced the publication of novel preclinical in vivo data and initial human data validating its therapeutic strategy in the peer-review INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.
Recent Events
24th Annual Biotech in Europe Forum
Meet Modiblast CEO Helga Schmetzer at Sachs Associates’ 24th Annual Biotech in Europe Forum in Basel from Sep 25-26.
Learn more
Press Releases
May 17, 2023
Modiblast MB101 program passes BfArM scientific advice and pre-CTA meeting without objections
Modiblast announced that its lead development program MB101 has passed a recent scientific advice and pre-CTA meeting with the BfArM without objections.
Learn more
April 19, 2021
Modiblast appoints Behrouz Mansouri as Medical Director to prepare transition into clinical development phase
Behrouz Mansouri’s appointment adds substantial clinical and medical expertise with a focus on hematology and hematology–oncology to Modiblast’s leadership team.
Learn more